Lupus-like onset of recurrent Kawasaki disease in an adolescent boy [4]

Clinical and Experimental Rheumatology

Volumn 22, Issue 3, 2004, Pages 377-

  Marchetto, S ^a   Chiappini, E ^a   Simonini, G ^a   Falcini, F ^a   de Martino, Maurizio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTINUCLEAR ANTIBODY; C REACTIVE PROTEIN; CARDIOLIPIN ANTIBODY; CLARITHROMYCIN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADOLESCENT; BLOOD CULTURE; CASE REPORT; CHEILITIS; CONJUNCTIVITIS; ERYTHROCYTE SEDIMENTATION RATE; FEVER; HUMAN; LABORATORY TEST; LETTER; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; RASH; RECURRENT DISEASE; SEROLOGY; SORE THROAT; URINE CULTURE;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; FIBRINOGEN; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; METHYLPREDNISOLONE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEUTROPHILS; RECURRENCE; TREATMENT OUTCOME;

EID: 2342558009     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. HIRATA S, NAKAMURA Y, YANAGAWA H: Incidence rate of recurrent Kawasaki disease and related risk factors: from the results of nationwide surveys of Kawasaki disease in Japan. Acta Pediatr 2001; 90: 40-4.
2. HAN RK, SILVERMAN ED, NEWMAN A et al.: Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease. Arch Paediatr Adolesc Med 2000; 154: 694-9.
3. SHULMAN ST: Is the role for corticosteroids in Kawasaki disease ? J Paediatr 2003; 142: 601-3.
4. SUNDEL RP, BAKER AL, FULTON DR et al.: Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial. J Paediatr 2003; 142: 611-6.
5. CALLAWAY LK, BENNETT CJ, CALLAWAY JK: Adolescent Kawasaki disease with uveitis. Intern Med J 2002; 32: 421-2.
6. HIROSE K, NAKAMURA Y, YANAGAWA H: Cardiac sequelae of Kawasaki disease in Japan over 10 years. Acta Paediatr Jpn 1995; 37: 667-71.
7. DE ZORZI A, COLAN SD, GAUVREAU K et al.: Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Paediatr 1998; 133: 254-8.
8. RIUZ-IRASTORZA G, KHAMASHTA MA, CASTELLINO G et al.: Systemic lupus erythematosus. Lancet 2001; 357; 1027-32.
9. Diagnostic guidelines for Kawasaki disease. Circulation 2001; 103: 335-6.
10. GUPTA M, JOHANN-LIANG R, BUSSEL JB et al.: Elevated IgA and IgM anticardiolipin antibodies in acute Kawasaki disease. Cardiology 2002; 97: 180-2.